References
- YeeRWThe effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: A reviewCurr Opin Ophthalmol200718213413917301615
- PisellaPJPouliquenPBaudouinCPrevalence of ocular symptoms and signs with preserved and preservative free glaucoma medicationBr J Ophthalmol200286441842311914211
- BaudouinCRianchoLWarnetJMBrignoleFIn vitro studies of antiglaucomatous prostaglandin analogues: Travoprost with and without benzalkonium chloride and preserved latanoprostInvest Ophthalmol Vis Sci20074894123412817724196
- KahookMYNoeckerRQuantitative analysis of conjunctival goblet cells after chronic application of topical dropsAdv Ther200825874375118670744
- McCareyBEdelhauserHIn vivo corneal epithelial permeability following treatment with prostaglandin analogs [correction of analoges] with or without benzalkonium chlorideJ Ocul Pharmacol Ther200723544545117941807
- WhitsonJCavanaghHLakshmanNPetrollWAssessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chlorideAdv Ther200623566367117142200
- MartoneGFrezzottiPTosiGMAn in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphologyAm J Ophthalmol2009147472573519181302
- IshibashiTYokoiNKinoshitaSComparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chlorideJ Glaucoma200312648649014646684
- HorsleyMBKahookMYEffects of prostaglandin analog therapy on the ocular surface of glaucoma patientsClin Ophthalmol2009329129519668581
- LeungEWMedeirosFAWeinrebRNPrevalence of ocular surface disease in glaucoma patientsJ Glaucoma200817535035518703943
- FechtnerRDGodfreyDGBudenzDStewartJAStewartWCJasekMCPrevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medicationsCornea201029661862120386433
- The International Dry Eye WorkShop Study GroupMethodologies to diagnose and monitor dry eye disease: Report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf20075210815217508118
- ScheinODMunozBTielschJMBandeen-RocheKWestSPrevalence of dry eye among the elderlyAm J Ophthalmol199712467237289402817
- HenryJCPeaceJHStewartJAStewartWCEfficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapyClin Ophthalmol20082361362119668762
- SchiffmanRMChristiansonMDJacobsenGHirschJDReisBLReliability and validity of the Ocular Surface Disease IndexArch Ophthalmol2000118561562110815152
- OzcuraFAydinSHelvaciMROcular surface disease index for the diagnosis of dry eye syndromeOcul Immunol Inflamm200715538939317972223
- MillerKLWaltJGMinkDRMinimal clinically important difference for the ocular surface disease indexArch Ophthalmol201012819410120065224
- KahookMYAmmarDAIn vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cellsJ Ocul Pharmacol Ther201026325926320565312
- HommerAMohammedROBurchertMKimmichFIOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucomaCurr Med Res Opin20102681905191320553122
- ChaSHLeeJSOumBSKimCDCorneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitroClin Exp Ophthalmol2004322180184
- DebbaschCBrignoleFPisellaPJWarnetJMRatPBaudouinCQuaternary ammoniums and other preservatives’ contribution in oxidative stress and apoptosis on Chang conjunctival cellsInvest Ophthalmol Vis Sci200142364265211222522
- EpsteinSPAhdootMMarcusEAsbellPAComparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cellsJ Ocul Pharmacol Ther200925211312019284328
- ChampeauEEdelhauserHHollyFLambertsDMacKeenDEffect of ophthalmic preservatives on the ocular surface: conjunctival and corneal uptake and distribution of benzalkonium chloride and chlorhexidine digluconateThe Preocular Tear Film in Health, Disease, and Contact Lens WearLubbock, TXDry Eye Institute, Inc1986
- MargoCEThe placebo effectSurv Ophthalmol1999441314410466586
- NicholsKKNicholsJJMitchellGLThe lack of association between signs and symptoms in patients with dry eye diseaseCornea200423876277015502475
- TsaiJCMcClureCARamosSESchlundtDGPichertJWCompliance barriers in glaucoma: A systematic classificationJ Glaucoma200312539339814520147
- LewisRAKatzGJWeissMJTravoprost 0.004% with and without benzalkonium chloride: A comparison of safety and efficacyJ Glaucoma20071619810317224758